1st Jun 2007 18:11
Microgen PLC01 June 2007 For immediate release 1 June 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTOTHE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY JURISDICTIONWHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCHJURISDICTION Recommended Cash Offer for the entire issued and to be issued share capital of Trace Group plc ("Trace") by Microgen plc ("Microgen") Offer Document Posted Further to the announcement on 25 May 2007 by Microgen regarding the recommendedcash offer at a price of 155 pence per Trace Share, the Board of Microgen announces that the Offer Document is today published and is being posted to Trace Shareholders. To accept the Offer in respect of Trace Shares held in certificated form (thatis, not through CREST), Trace Shareholders should complete, sign and return theForm of Acceptance (which has been posted to Trace Shareholders along with the Offer Document) in accordance with the instructions thereon and the instructionsin the Offer Document as soon as possible and, in any event, so as to be received by Capita Registrars by no later than 1.00 p.m. London time on 25 June 2007. To accept the Offer in respect of Trace Shares held in uncertificated form(that is, through CREST), Trace Shareholders should submit a TTE instruction in accordance with the instructions in the Offer Document for settlement as soon aspossible and, in any event, by no later than 1.00 p.m. London time on 25 June 2007. The Offer Document will be available for inspection on Microgen's website -www.microgen.co.uk and copies of the Offer Document and the Form of Acceptance(for use by holders of Trace Shares in certificated form only) will be availablefor inspection during normal business hours on any weekday (Saturdays, Sundaysand public holidays excepted) at the registered office of Clyde & Co LLP at 51Eastcheap, London EC3M 1JP until the end of the Offer Period. Capitalised terms used, but not defined in this announcement have the samemeaning as given to them in the Offer Document. Enquiries:Microgen plc Tel: +44 (0) 1252 772 300Martyn RatcliffePhilip Wood Arbuthnot Securities Limited Tel: +44 (0) 20 7012 2000(Financial adviser and broker to Microgen in relation to the Offer)Ian WilliamsRichard Tulloch Financial Dynamics Tel: +44 (0) 20 7831 3113(Public relations adviser to Microgen)Giles Sanderson Arbuthnot Securities, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for Microgen and no oneelse in connection with the Offer and will not be responsible to anyone otherthan Microgen for providing the protections afforded to clients of ArbuthnotSecurities nor for providing advice in relation to the Offer, or the contents ofthis Announcement or any matter referred to herein. This announcement is not intended to and does not constitute, or form any partof, an offer or an invitation to purchase or sell any securities or thesolicitation of any vote or approval in any jurisdiction pursuant to the Offeror otherwise. The Offer will be made solely through the Offer Document, and, inrelation to certificated Trace Shares, the Form of Acceptance. The OfferDocument and the Form of Acceptance will together contain the full terms andconditions of the Offer, including details of how to accept the Offer. Anyacceptance or other response to the Offer should be made only on the basis ofthe information contained in the Offer Document and the Form of Acceptance. TheOffer will be subject to English Law. The laws of relevant jurisdictions mayaffect the availability of the Offer to overseas persons. Overseas persons, orpersons who are subject to the laws of any jurisdiction other than the UnitedKingdom, should inform themselves about and observe any applicable legal andregulatory requirements. The Offer Document will be available for publicinspection in the United Kingdom. Unless otherwise determined by Microgen, the Offer will not be made, directly orindirectly, in or into the United States or by use of the mails of, or by anymeans or instrumentality (including, without limitation, facsimile, internet,email or other electronic transmission, telex or telephone) of inter-state orforeign commerce of, or any facility of a national, state or other securitiesexchange of, the United States, nor will it be made directly or indirectly in orinto Canada, Australia, Japan or any Restricted Jurisdiction, and the Offer willnot be capable of acceptance by any such use, means, instrumentality or facilityor from within the United States, Canada, Australia, Japan or any RestrictedJurisdiction. Accordingly, copies of this announcement are not being, will notbe and must not be, directly or indirectly, mailed or otherwise forwarded,transmitted, distributed or sent in, into or from the United States, Canada,Australia, Japan or any Restricted Jurisdiction, and persons receiving thisannouncement (including, without limitation, custodians, nominees and trustees)must not mail, forward, distribute or send it in, into or from the UnitedStates, Canada, Australia, Japan or any Restricted Jurisdiction. Doing so mayrender invalid any purported acceptance of the Offer. Any persons (includingcustodians, nominees and trustees) who are overseas persons or who would, orotherwise intend to, mail or otherwise forward, transmit, distribute or sendthis Announcement, the Offer Document, the Form of Acceptance or any relateddocument outside the United Kingdom or to any overseas person should seekappropriate advice before doing so. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Aptitude